Evidence map›Paper›PMID 42712997›Full record

ArticleBrain communications2026

Cumulative incidence and risk factors of dementia in Parkinson's disease and parkinsonism: a population-based study.

Lorenzo Malfer, Aidan F Mullan, Elena Lynott, Colton Troxel, Farwa Ali, Eduardo E Benarroch, Bradley F Boeve, James H Bower, Rodolfo Savica

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lorenzo MalferDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID https://orcid.org/0009-0009-0034-6590
Aidan F MullanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Elena LynottDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID https://orcid.org/0009-0001-9701-362X
Colton TroxelDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Farwa AliDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Eduardo E BenarrochDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-4153-8187
James H BowerDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Rodolfo SavicaDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-2543-0627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive impairment is among the most common non-motor symptoms in parkinsonism and Parkinson's disease, ranging from subjective complaints to dementia. Although several predictive factors have been described, their prognostic relevance remains uncertain. This study aimed to examine the predictive association between clinical features and the risk of dementia and determine the incidence of dementia in a population-based cohort of incident Parkinsonism cases. Patients with parkinsonism onset between 1991 and 2020 were identified using the Rochester Epidemiology Project records-linkage system. Subjects with cognitive impairment preceding motor symptoms onset or concomitant Alzheimer's disease were excluded. Diagnoses of dementia and mild cognitive impairment were established using neuropsychological testing or brief cognitive screening. Development of dementia was assessed using a Cox proportional hazards regression model. Associations between dementia and each risk factor were individually estimated in adjusted Cox models. All risk factors were also included in a least absolute shrinkage and selection operator penalized multivariable Cox model. A total of 1104 patients were included: 153 (13.9%) developed mild cognitive impairment, and 543 (49.2%) developed dementia during follow-up. The cumulative incidence of dementia was 30.3% at 5 years, 48.6% at 10 years, 61.4% at 15 years and 69.3% at 20 years, indicating that a considerable portion of patients remained free of dementia after a prolonged follow-up. The majority of patients with dementia were males (61.5%), and older age at disease onset was associated with risk of dementia (hazard ratio [HR] = 1.32,

Indexed as

dementiaeye movement abnormalitiesnon-motor symptomsparkinsonismParkinson’s disease

Identifiers

PMID42712997
PMCPMC13551027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.